Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ERTAPENEM FOR INJECTION DIN 02539799

Status: Cancelled Pre Market
Holder: MANTRA PHARMA INC
Molecule: ERTAPENEM (ERTAPENEM SODIUM)

Health Canada record

Active ingredient(s)ERTAPENEM (ERTAPENEM SODIUM) 1 G
Dosage formPowder For Solution
RouteIntramuscular; Intravenous
SchedulePRESCRIPTION
ClassHuman
ATCJ01DH03 ERTAPENEM
Original market date
Current status date12-Jul-2024
SourceHealth Canada DPD

Establishment licence of the holder

Mantra Pharma Inc. — licence 101740, currently licensed, last inspection rating C (2023-05-10).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing ERTAPENEM (ERTAPENEM SODIUM)

DINProductCompanyFormStrengthStatus
02537176ERTAPENEM FOR INJECTIONEUGIA PHARMA INC.Powder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GMarketed
02490773ERTAPENEM FOR INJECTIONJUNO PHARMA CANADA INC.Powder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GMarketed
02492148ERTAPENEM FOR INJECTIONAURO PHARMA INCPowder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GMarketed
02496127ERTAPENEM FOR INJECTIONFRESENIUS KABI CANADA LTDPowder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GMarketed
02505126ERTAPENEM FOR INJECTIONHIKMA CANADA LIMITEDPowder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GApproved
02511150ERTAPENEM FOR INJECTIONDR REDDY'S LABORATORIES LTDPowder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GMarketed
02247437INVANZMERCK CANADA INCPowder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GMarketed
02539500ERTAPENEM FOR INJECTIONOMEGA LABORATORIES LIMITEDPowder For SolutionERTAPENEM (ERTAPENEM SODIUM) 1 GCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
312562023-07-20Abbreviated New Drug Submission (ANDS)Administrative: Licensing Agreement Between Two Manufacturers
Request a quote for ERTAPENEM FOR INJECTION

How to read a Canadian DIN record